home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

11 rows where docket_id = "FDA-2013-D-1445" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 4

  • 2014 4
  • 2020 3
  • 2016 2
  • 2018 2

document_type 2

  • Notice 6
  • Other 5

agency_id 1

  • FDA 11
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2013-D-1445-0074 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff Other Guidance 2020-10-05T04:00:00Z 2020 10 2020-10-05T04:00:00Z   2024-11-06T23:40:06Z   1 0 09000064848d3169
FDA-2013-D-1445-0073 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Guidance for Industry and Food and Drug Administration Staff Other Guidance 2020-09-29T04:00:00Z 2020 9 2020-09-29T04:00:00Z   2024-11-06T23:40:18Z   1 0 090000648489b73e
FDA-2013-D-1445-0072 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff; Availability Notice Notice of Availability 2020-09-29T04:00:00Z 2020 9 2020-09-29T04:00:00Z   2020-09-29T19:06:55Z 2020-21463 0 0 090000648489886d
FDA-2013-D-1445-0065 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Availability Notice Notice of Availability 2018-11-30T05:00:00Z 2018 11 2018-11-30T05:00:00Z 2019-03-01T04:59:59Z 2024-11-12T22:50:38Z 2018-26034 1 0 0900006483916275
FDA-2013-D-1445-0066 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Draft Guidance for Industry and Food and Drug Administration Staff Other Guidance 2018-11-30T05:00:00Z 2018 11 2018-11-30T05:00:00Z   2024-11-12T22:49:53Z   1 0 09000064839196ea
FDA-2013-D-1445-0062 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff; Availability Notice Notice of Availability 2016-10-11T04:00:00Z 2016 10 2016-10-11T04:00:00Z   2016-10-11T15:17:52Z 2016-24430 0 0 09000064822d1a6d
FDA-2013-D-1445-0063 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff Other Guidance 2016-10-11T04:00:00Z 2016 10 2016-10-11T04:00:00Z   2024-11-11T21:32:39Z   1 0 09000064822dd986
FDA-2013-D-1445-0013 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Extension of Comment Period Notice Extension of Comment Period 2014-04-09T04:00:00Z 2014 4 2014-04-09T04:00:00Z 2014-05-08T03:59:59Z 2014-05-09T01:02:01Z 2014-07898 0 0 09000064816ab265
FDA-2013-D-1445-0012 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Extension of Comment Period Notice   2014-04-09T00:00:00Z 2014 4     2014-04-09T15:35:53Z   0 1 09000064816ab3db
FDA-2013-D-1445-0002 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff Other Guidance 2014-01-08T05:00:00Z 2014 1 2014-01-08T05:00:00Z   2024-11-07T23:01:39Z   1 0 09000064814f47d7
FDA-2013-D-1445-0001 FDA None FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Availability Notice Notice of Availability 2014-01-07T05:00:00Z 2014 1 2014-01-07T05:00:00Z 2014-04-08T03:59:59Z 2014-07-01T17:05:55Z 2014-00023 0 0 09000064814f130a

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 535.917ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API